文献速递眼底病与葡萄膜炎

年龄相关性黄斑变性接受阿柏西普治疗后脉络膜新生血管病灶活动性复发

RECURRENCE OF CHOROIDAL NEOVASCULARIZATION LESION ACTIVITY AFTER AFLIBERCEPT TREATMENT FOR AGE-RELATED MACULAR DEGENERATION.
PubMed 文献 · Retina · 2017-01-01

回顾性分析98只接受1年阿柏西普固定方案治疗且随访至少18个月的初治渗出性年龄相关性黄斑变性眼,第12个月时69只眼黄斑干燥,Kaplan-Meier分析显示后续12个月内43.7%出现复发;在息肉状脉络膜血管病变眼中,第12个月残留息肉和色素上皮脱离形态与复发显著相关(P=0.018和0.048)。

要点

  • 98只眼中69只第12个月黄斑干燥,后续12个月Kaplan-Meier复发率43.7%。
  • AMD总体未检出与复发相关的因素。
  • PCV眼中残留息肉和PED形态与复发显著相关(P=0.018和0.048)。

核心结论

  • 对超过半数达到黄斑干燥的AMD眼,持续主动治疗可能属于过度治疗。
  • 血管造影和光学相干断层扫描分析可能有助于预测PCV眼的复发。

研究设计与样本

  • 回顾性评估接受1年阿柏西普固定方案治疗且自首次注射起随访至少18个月的初治渗出性AMD眼,共98只眼。

主要发现

  • 98只眼中69只第12个月检查时黄斑干燥。
  • Kaplan-Meier分析显示后续12个月期间复发率为43.7%。
  • AMD总体未检出与复发相关的因素。
  • PCV眼中第12个月残留息肉与复发显著相关(P=0.018)。
  • PCV眼中第12个月PED形态与复发显著相关(P=0.048)。

临床怎么用

  • 原文结论认为对超过半数达到黄斑干燥的AMD眼持续主动治疗可能属于过度治疗。
  • 作者认为血管造影和OCT分析可能有助于预测PCV眼的复发。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine the recurrence rate of choroidal neovascularization (CNV) lesion activity in age-related macular degeneration (AMD) and associated factors after 1-year aflibercept treatment. METHODS: Age-related macular degeneration eyes with 1-year aflibercept fixed-regimen treatment and a follow-up period of at least 18 months from the initial aflibercept injection for treatment-naive exudative AMD were retrospectively evaluated. The recurrence rate was examined. Age, gender, visual acuity, AMD subtype, greatest linear dimension, and retinal and choroidal thicknesses at the 12th month examination were compared between eyes with and without recurrence. Presence of remnant polyps and pigment epithelial detachment (PED) morphology were also compared in polypoidal choroidal vasculopathy (PCV) eyes. RESULTS: Of the 98 eyes studied, 69 displayed a dry macula at the 12th month examination; 43.7% exhibited recurrence during the subsequent 12-month period in Kaplan-Meier analysis. Although no factors associated with recurrence were detected in AMD, remnant polyps and pigment epithelial detachment morphology at the 12th month examination were significantly associated with recurrence in polypoidal choroidal vasculopathy (P = 0.018 and 0.048, respectively). CONCLUSION: Continuous, proactive treatment would be considered overtreatment for more than half of the AMD eyes that achieved a dry macula. Angiography and optical coherence tomography analyses may be useful for predicting recurrence in polypoidal choroidal vasculopathy eyes.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Wakazono T, Yamashiro K, Oishi A, et al. RECURRENCE OF CHOROIDAL NEOVASCULARIZATION LESION ACTIVITY AFTER AFLIBERCEPT TREATMENT FOR AGE-RELATED MACULAR DEGENERATION. Retina. 2017. PMID: 28590316. doi:10.1097/IAE.0000000000001451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。